首页> 中文期刊> 《山东医药》 >三种 PML/RARA 亚型急性早幼粒细胞白血病临床特点对比分析

三种 PML/RARA 亚型急性早幼粒细胞白血病临床特点对比分析

         

摘要

Objective To analyze and compare the clinical characteristics of acute promyelocytic leukemia ( APL) with promyelocytic leukemia ( PML)/retinoic acid receptorαgene ( RARA) different isoforms.Methods The clinical data from 108 APL patients in our center from 2010 to 2014 were collected and the PML/RARA different isoforms were ana-lyzed.Results ①The most common PML/RARA subtype was L isoform, which were 67 cases (62.0%), followed by 30 cases of S (27.8%) and 11 cases of V (10.2%) .②The bleeding was less frequently found in V isoform (45.5%) than in L isoform (74.6%) and S isoform (86.7%) (P=0.026).The median fibrinogen level in V isoform (1.98 g/L) was higher than that in L isoform (1.18 g/L) and S isoform (1.05 g/L) (P=0.024).③The prevalence of FLT3/ITD muta-tion was more frequently found in S isoform (26.7%) than in L isoform (7.6%) and V isoform (0%) (P=0.013).The positive rate of CD34 expression was higher in S isoform (24.1%) than in L isoform (6.3%) and V isoform (11.1%) (P=0.046).④The incidences of retinoic acid syndrome in the high risk group, medium risk group and low risk group were 56.3%, 28.8%and 17.5%, respectively (P=0.021).The difference of the incidence of retinoic acid syndrome in three PML/RARA isoforms was not significant (P=0.643).Conclusions The clinical characteristics of three PML/RARA iso-forms were not exactly the same.The most common subtype was L isoform, the lowest incidence of bleeding was found in V isoform, and S isoform was most likely to be accompanied by FLT3/ITD mutation and CD34 expression.%目的:分析并比较不同早幼粒细胞白血病/维甲酸受体α融合基因( PML/RARA)亚型急性早幼粒细胞白血病( APL)的临床特点。方法收集我中心2010~2014年108例初诊APL患者的临床资料,分析不同PML/RARA亚型的特点。结果最常见的PML/RARA亚型为L型(67例,62.0%),其次为S型(30例,27.8%)、V型(11例,10.2%)。 V型患者合并出血的比例(45.5%)低于L型(74.6%)和S型(86.7%),P均<0.05;V型患者中位纤维蛋白原水平(1.98 g/L)高于L型(1.18 g/L)和S型(1.05 g/L),P均<0.05。 S型患者(26.7%)较L型(7.6%)和V型(0)更易伴发FMS样酪氨酸酶3内部串联重复(FLT3/ITD)突变,P均<0.05。 S型患者CD34表达阳性率(24.1%)高于L型(6.3%)和V型(11.1%),P均<0.05。高、中、低危组维甲酸综合征发生率分别为56.3%、28.8%、17.5%( P均<0.05)。三种PML/RARA亚型维甲酸综合征的发生率差异无统计学意义。结论三种PML/RARA亚型的APL临床特点不尽相同,L型最常见,V型出血发生率较低,S型较易伴FLT3/ITD突变和CD34阳性表达。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号